4

FORM 4 SUBMISSION

Company: Dianthus Therapeutics, Inc. /DE/
Filed: August 1, 2022
Period of Report: August 1, 2022
Accession Number: 0000899243-22-027265

View Document ↗ View on SEC.gov ↗